孟鲁司特钠治疗小儿支气管哮喘的临床疗效观察

Clinical Effect Observation of the Treatment of Bronchial Asthma in Children with Montelukast Sodium

目的探讨孟鲁司特钠治疗小儿支气管哮喘的治疗方法以及临床疗效。方法 2012年3月至2016年1月本院对收治的100例支气管哮喘患儿随机分为观察组和对照组。每组50例,其中对照组给予常规治疗,观察组在对照组治疗的基础上加用孟鲁司特钠口服治疗,总疗程3个月,比较2组疗效。结果治疗组总有效率为96.0%高于对照组的82.0%,差异有统计学意义(P<0.05)。结论孟鲁司特钠治疗小儿支气管哮喘的疗效显著,可减少哮喘发作,是临床治疗哮喘的有效方法之一,值得临床推广应用。

Objective To explore the treatment of montelukast sodium in children with bronchial asthma treatment and clinical efficacy. Methods 100 children with bronchial asthma were randomly divided into the observation group and the control group in March 2012 to January 2016. Each group of 50 cases, the control group was given conventional treatment, the observation group in the control group on the basis of the treatment with montelukast sodium treatment, the total course of treatment for 3 months, compared with 2 groups of curative effect. Results The total effective rate of the treatment group Was 82.0% higher than that of the control group（96.0%）, and the difference was statistically significant （P〈0.05）. Conclusion The curative effect of the treatment of bronchial asthma in children with bronchial asthma is significant, can reduce asthma attack, it is one of the effective methods of clinical treatment of asthma, it is worthy of clinical application.